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Purpose: To identify the minimum number of measurements required for the 
noninvasive assessment of liver fibrosis by using point shear-wave 
elastography (pSWE) and determine whether the use of a reliability 




Ten liver shear-wave velocity (SWV) measurements by pSWE were 
obtained in 232 participants. Interclass correlation coefficients (ICC) 
between the median of the first two through the first nine mea-
surements and all 10 measurements were calculated; the minimum 
number of measurements with ICC greater than 0.95 versus all 10 
measurements was determined. The diagnostic performance of the 
minimum number of measurements and 10 measurements in identify-
ing significant (Ishak stage, 3) and severe fibrosis or cirrhosis (Ishak 
stage, 5) was compared by using areas under the receiver operating 
characteristic curve. These were compared between measurements 
that demonstrated higher or lower reliability (IQR-to-median ratio of 
 30% and IQR-to-median ratio of . 30%, respectively).
Results: Compared with 10 measurements, a minimum of six SWV measure-
ments was required. The overall area under the curve for diagnosing 
significant (areas under the receiver operating characteristic curve, 
0.828 vs 0.839; P = .487) and severe fibrosis or cirrhosis (0.953 vs 
0.969, respectively; P = .145) did not differ according to number 
of measurements (six vs 10); a median of six measurements re-
sulted in only limited disagreement (nine of 232 [3.9%]) versus his-
tologic evaluation. When using 10 measurements, higher reliability 
measurements showed a lower percentage of discordance between 
pSWE and significant fibrosis and severe fibrosis or cirrhosis (22 
[14.7%] and three [2.0%] of 150 cases, respectively) compared 
with lower reliability measurements (26 [31.7%] and eight [9.8%] 
of 82 cases, respectively). Significant fibrosis was an independent 
predictor for lower reliability (hazard ratio, 2.22; P , .020).
Conclusion: A limited number of SWV measurements (median six vs median 10) 
were required for the assessment of liver fibrosis by using pSWE. 
The number of measurements had less influence on the diagnostic 
accuracy compared with lower reliability measurements.
q RSNA, 2018
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B, C, and combined B/C/D; alcoholic 
liver disease; nonalcoholic fatty liver 
disease; and autoimmune and inflamma-
tory disease. Aspartate aminotransfer-
ase, alanine aminotransferase, g glutamyl 
transferase, total bilirubin, platelet count, 
international normalized ratio, and alka-
line phosphatase were measured.
pSWE Examination
All patients and healthy volunteers fasted 
overnight and were scanned in a supine 
position with arms extended over their 
head, in suspended respiration, in accor-
dance with guidelines (21). The pSWE 
examination was performed by trained 
radiologists (C.F., O.S.J., G.T.Y., E.K.) 
who had at least 2 years of ultrasono-
graphic (US) experience and training in 
the pSWE technique (each of them per-
formed at least 200 previous liver elas-
tography examinations per the European 
Federation of Societies for Ultrasound 
in Medicine and Biology competency 
requirement). pSWE was performed 
with a quantitative software technique 
(Virtual Touch Quantification; Siemens 
Healthcare, Mountain View, Calif) by us-
ing a US imaging system (Acuson S2000/
S3000; Siemens), equipped with a con-
vex broadband (6C1, 1.5 MHz–6 MHz) 
transducer. A region-of-interest box was 
measurements and quality measures 
required. Recent guidelines from the 
European Federation of Societies for 
Ultrasound in Medicine and Biology 
suggest that at least 10 measurements 
should be used for liver fibrosis mea-
surements and discuss the potential 
role of the interquartile range (IQR)-
to-median ratio as a reliability indicator 
(21). However, the practice of acquir-
ing 10 measurements appears to be a 
common convention rather than deter-
mined by systematic evaluation.
The purpose of this study was to 
identify the minimum number of mea-
surements required for the noninvasive 
assessment of liver fibrosis by using 
pSWE and to determine whether the 
use of a reliability indicator such as 
IQR-to-median ratio will affect diagnos-
tic performance.
Materials and Methods
This retrospective analysis was per-
formed with local ethics approval for 
several prospective SWE studies per-
formed at our institution (12). Written 
informed consent was obtained from 
all patients and healthy volunteers who 
participated in each study.
Study Population
Between October 2009 and July 2015, 
232 patients and healthy volunteers 
who underwent pSWE were retrospec-
tively reviewed. pSWE measurements 
from 11 healthy volunteers were used 
in a previous study (12); this previous 
study focused on the reproducibility of 
two-dimensional SWE by comparing it 
with pSWE. There was no overlap with 
our analysis.
The patient cohort, including 221 
patients suspected of having chronic 
liver disease who underwent pSWE 
to evaluate the degree of liver fibrosis, 
has not been previously reported. The 
demographic characteristics of the pa-
tient and healthy volunteers are listed in 
Table 1. The patients attended the Ra-
diology Department Day Case Unit to 
undergo liver biopsy to assess their un-
derlying disease; the pSWE examination 
was performed on the same day. The 





ICC = interclass correlation coefficient
IQR = interquartile range
pSWE = point SWE
SWE = shear-wave elastography
SWV = shear-wave velocity
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Implication for Patient Care
 n Our results demonstrate that six 
measurements have excellent re-
liability compared with 10 mea-
surements when conducting 
point shear-wave elastography 
evaluation of liver fibrosis and 
results in limited disagreement 
(3.9% of cases) verus histologic 
evaluation, potentially allowing 
less time required to acquire 
measurements.
L iver biopsy is a so-called reference standard in the evaluation of the degree of liver fibrosis in patients 
with chronic liver disease (1). However, 
noninvasive methods for assessment of 
liver fibrosis including shear-wave elas-
tography (SWE) have gained increasing 
acceptance, obviating the need for a 
liver biopsy, a diagnostic procedure as-
sociated with substantial morbidity and 
mortality (2,3). SWE involves mechan-
ical excitation of tissue with a short 
duration of an acoustic push pulse, 
which generates localized displace-
ment in tissue resulting in shear-wave 
propagation. The speed of shear-wave 
propagation within the tissue measured 
in meters per second is related to the 
stiffness of the tissue (4,5). Previous 
studies (6–13) demonstrated that point 
SWE (pSWE) is a reliable and accurate 
technique in assessing the stage of liver 
fibrosis in both healthy volunteers and 
patients with chronic liver disease. This 
noninvasive diagnostic method is in-
cluded in current clinical guidelines for 
the initial assessment of liver fibrosis or 
cirrhosis, with liver biopsy reserved for 
patients in whom there is uncertainty 
about potential additional etiologic 
causes of liver disease (14,15).
The majority of previous studies 
that evaluated pSWE to stage liver fi-
brosis used 10 valid measurements and 
reported median or mean values, with 
some studies using a median of five 
(16), six (17,18), 12 (19), or 20 (20) 
measurements. Unlike transient elas-
tography where 10 measurements are 
recommended, limited information is 
provided in pSWE manufacturer guide-
lines about the number of repeated 
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Statistical Analysis
Statistical analysis was performed by us-
ing software (SPSS for Windows version 
22, IBM, Chicago, Ill; and MedCalc for 
windows, v17.6, MedCalc Software, Os-
tend, Belgium). To determine the min-
imum number of SWV measurements 
required, interclass correlation coeffi-
cients (ICCs) and 95% confidence inter-
vals were obtained between subsets of 
median values from the initial second to 
ninth measurement, and the reference 
median value from 10 measurements. 
In addition, Wilcoxon signed-rank tests 
were used to determine whether there 
was significant difference in accuracy be-
tween the median of the first five and the 
median of the last five measurements. 
The minimum number of measure-
ments with an ICC threshold of greater 
than 0.95 (ie, an error of less than 5%) 
versus that from all 10 measurements 
was determined. Bland-Altman 95% 
confidence intervals were calculated to 
assess the agreement between the me-
dian value of the minimum number of 
measurements and the median of 10 
measurements. Any difference in con-
tinuous variables between patients with 
an IQR-to-median ratio of 30% or less 
or an IQR-to-median ratio of greater 
than 30% was analyzed by using Mann-
Whitney U test (ie, nonparametric data) 
or t test (ie, parametric data). The x2 
test or Fisher exact test was used for 
categorical variables. All variables that 
were significantly associated with IQR-
to-median ratio greater than 30% at uni-
variate analysis were analyzed by using 
multivariable logistic regression analysis. 
Correlation between the SWV measure-
ments and fibrosis stages was assessed 
by using Spearman rank correlation 
coefficient (r). The diagnostic perfor-
mance of the median value of the min-
imum number of pSWE measurements 
and the reference median value were 
assessed by receiver operator charac-
teristic curves. Differences between the 
areas under the receiver operating char-
acteristic curve were compared by us-
ing a Delong test (24). The optimal cut-
off value was determined by using the 
Youden index (25). Subgroup diagnostic 
performance analyses were performed 
by using participants with measurements 
placed in the right lobe of the liver at a 
depth between 2 and 6 cm, avoiding bil-
iary ducts and large vessels by using an 
intercostal scanning approach (Fig 1). 
The tissue elasticity analysis was per-
formed by using software (Virtual Touch 
Quantification; Siemens) that quantified 
liver stiffness as shear-wave velocity 
(SWV) in meters per second during brief 
breath-holding in a neutral position (5 
seconds). Ten consecutive valid SWV 
measurements were recorded without 
discarding any results. These measure-
ments were divided into those that had 
an IQR-to-median ratio of greater than 
30% and 30% or less; the latter were 
considered to indicate reliable results. 
Failure of pSWE measurement was de-
fined as the inability to obtain a valid 
measurement (displayed on the screen 
as X.XX) after 10 attempts.
Histologic Evaluation
Core liver biopsy samples were taken 
from the right lobe of the liver by us-
ing an 18-gauge needle (Bard Marquee 
Disposable Core Biopsy Instrument; 
Bard Biopsy Systems, Tempe, Ariz) and 
prepared per standard departmental 
protocol. Biopsy fragments of 15 mm 
or greater were considered appropri-
ate for pathologic evaluation. Biopsies 
were examined by a single hepatobili-
ary pathologist (A.Q., with .20 years 
of experience) who was blinded to the 
SWV measurements. Ishak fibrosis 
staging system was used to evaluate 
pathologic liver fibrosis and inflamma-
tory activity (Table E1 [online]) (22). 
Significant fibrosis was defined as Ishak 
stage 3 and above, and severe fibro-
sis or cirrhosis was defined as Ishak 
stage 5 and above. The fibrosis stages 
of healthy volunteers were Ishak stage 
0. The degree of steatosis was classi-
fied by visual estimation of the biopsy 
sample according to the percentage 
of hepatocytes with fatty changes: 
none (0% of hepatocytes), mild 
(33%), moderate (33%–66%), or 
marked (>66%) (23). The presence of 
steatosis is assumed to be none or mild 
for the healthy volunteers. Steatosis 
was grouped into no or mild steatosis 
and moderate or marked steatosis for 
the statistical analysis.
Table 1
Demographic Characteristics of 
the Study Patients and Healthy 
Volunteers
Parameter Result
Age (y)* 42 (18–70)
Sex (no. of patients)
 Female 85 (36.6)
 Male 147 (63.4)
Diagnosis (no. of participants) 
 Healthy volunteers 11 (4.7)
 Chronic hepatitis B infection 111 (47.8)
 Chronic hepatitis C infection 65 (28.0)
 Chronic hepatitis B/C/D  
 coinfections
3 (1.3)
 NAFLD/ALD 16 (6.9)
 Autoimmune 10 (4.3)
 Inflammatory (PSC/UC) 7 (3.0)
 Other/unknown etiologic  
 cause
9 (3.9)
Steatosis (no. of incidences)
 None 96 (41.4)
 Mild 66 (28.4)
 Moderate 19 (8.2)
 Marked 5 (2.2)
 Not available including  
 11 health volunteers
46 (19.8)
Ishak histologic fibrosis stage  
 (no. of patients) 
 0 29 (12.5)
 1 62 (26.7)
 2 39 (16.8)
 3 36 (15.5)
 4 22 (9.5)
 5 12 (5.2)
 6 32 (13.8)
 AST (U/L) 36 (15–1413)
 ALT (U/L) 43 (10–341)
 GGT (U/L) 35 (6–1391)
 ALP (U/L) 77.5 (16–584)
 Total bilirubin (µmol/L) 10 (4–122)
 INR 1.03 (1–2)
 Platelets (3109/L) 209 (37–661)
Note.—Median variables had nonnormal distribution. 
Unless otherwise indicated, data in parentheses are 
percentages. ALD = alcoholic liver disease, ALP = 
alkaline phosphatase, ALT = alanine aminotransferase 
aminotransferase, AST = aspartate, GGT = g glutamyl 
transferase, INR = international normalized ratio, NAFLD 
= nonalcoholic fatty liver disease, PSC = primary 
sclerosing cholangitis, UC = ulcerative colitis.
*Data are median; data in parentheses are range.
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measurements that demonstrated IQR-
to-median ratio of greater than 30%, 
the range of ICC was between 0.859 
(95% confidence interval: 0.790, 0.907; 
two measurements) and 0.991 (95% 
confidence interval: 0.986, 0.994; nine 
measurements), and the median of the 
first eight measurements and 10 mea-
surements demonstrated an ICC value 
above 0.95. There was no significant 
difference between the ICC by using the 
median of the first five measurements 
(ie, measurements from one to five) 
versus the median of the second five 
measurements (ie, measurements from 
six to 10) (P = .562). In the subgroup 
analysis of patients with no or mild 
steatosis (n = 162), or moderate or 
marked steatosis (n = 24), the number 
minimum measurements required was 
eight for both subgroups.
Comparison of Performance for the 
Fibrosis Assessment by Using Median of 
Different Number of Measurements
The median SWVs increased with high-
er Ishak stage of fibrosis (1.176 m/sec 
confidence interval: 0.873, 0.922) to 
0.995 (95% confidence interval: 0.993, 
0.996) (Table 2). The ICC between the 
median of the first six measurements 
and median of all 10 measurements was 
0.966 (95% confidence interval: 0.957, 
0.974), which is the minimum number 
of measurements that demonstrate an 
ICC above the cutoff value of 0.95. The 
Bland-Altman analysis shows that the 
mean difference between median of 
six and median of 10 measurements is 
20.002 m/sec (95% confidence interval: 
20.33, 0.32) with no statistically signif-
icant systematic bias (P = .82) (Fig 2).
The ICC for the 150 patients and 
healthy volunteers with IQR-to-median 
ratio 30% or less ranged from 0.939 
(95% confidence interval: 0.916, 0.955; 
two repeated measurements) to 0.998 
(95% confidence interval: 0.997, 0.999; 
nine repeated measurements), and 
the ICC between the median of the 
first three repeated measurements 
and 10 measurements demonstrated 
an ICC value above 0.95. In the co-
hort of patients and volunteers with 
that demonstrated an IQR-to-median ra-
tio greater than 30% and IQR-to-median 
ratio of 30% or less. A two-sided P value 




The characteristics of the study patients 
and healthy volunteers are listed in Table 
1. Histologic grading of liver fibrosis was 
available from 221 patients. The 11 healthy 
volunteers did not undergo liver biopsy. 
SWV measurements were obtained in all 
232 patients and healthy volunteers who 
underwent pSWE. SWV measurements 
with lower reliability (IQR-to-median ra-
tio, .30%) were observed in 82 of the 
enrolled participants (35.3%).
ICCs between Median Measurements
In the overall cohort, the ICC between 
a median of two to a median of nine 
measurements and a median of 10 mea-
surements ranged from 0.901 (95% 
Figure 1
Figure 1: Point shear-wave elastographic examination of the liver performed by using an S2000 US machine (Sie-
mens, Healthcare). The liver capsule and region of interest are shown.
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(22.0%) with a median of six measure-
ments (Table 4). Of the additional three 
patients with discordance, one patient 
had an IQR-to-median ratio greater 
than 30%. The number of patients with 
discordance between pSWE and his-
tologic results for classification of se-
vere fibrosis or cirrhosis (Ishak stage, 
the subgroups with an IQR-to-median 
ratio greater than 30% and an IQR-to-
median ratio of 30% or less (Table 3).
The number of patients with dis-
cordance between pSWE and histologic 
results that classified significant fibrosis 
(Ishak stage 3) was 48 (20.7%) with 
a median of 10 measurements and 51 
[stage 0], 1.133 m/sec [stage 1], 1.191 
m/sec [stage 2], 1.358 m/sec [stage 
3], 1.594 m/sec [stage 4], 2.145 m/sec 
[stage 5], and 2.650 m/sec [stage 6]), 
with a significant difference between 
the different stages of fibrosis (P  
.001).
The median of 10 SWV measure-
ments differentiated significant fibrosis 
(Ishak stage 0–2 vs 3–6) and severe 
fibrosis or cirrhosis (Ishak stage 0–4 
vs 5–6) with an area under the re-
ceiver operating characteristic curve of 
0.839 (95% confidence interval: 0.786, 
0.884) and 0.969 (95% confidence in-
terval: 0.937, 0.987), respectively. The 
median of six SWV measurements dif-
ferentiated significant fibrosis (Ishak 
stage 0–2 vs 3–6) and severe fibrosis 
or cirrhosis (Ishak stage 0–4 vs 5–6), 
with an area under the receiver operat-
ing characteristic curve of 0.828 (95% 
confidence interval: 0.773, 0.874) and 
0.953 (95% confidence interval: 0.918, 
0.977), respectively. There was no 
statistically significant difference in 
the area under the receiver operating 
characteristic curve between the me-
dian of six SWV and 10 SWV measure-
ments in diagnosing both significant 
fibrosis (P = .487) and severe fibro-
sis or cirrhosis (P = .145). Similarly, 
there was no statistically significant 
difference in differentiating significant 
or severe fibrosis between a median of 
six and median of 10 measurements in 
Table 2
Interclass Correlation Coefficients between the Median Shear-Wave Velocity Value of Repeated Shear-Wave Elastography 
Measurement and Median of 10 Measurements
No. of Repetitions All Participants (n = 232)
Participants with High  
Reliability (n = 150)
Participants with Low  
Reliability (n = 82)
Participants with No or  
Mild Steatosis (n = 162)
Participants with Moderate or  
Severe Steatosis (n = 24)
2 0.901 (0.873, 0.922) 0.939 (0.916, 0.955) 0.859 (0.790, 0.907) 0.853 (0.804, 0.890) 0.755 (0.513, 0.886)
3 0.903 (0.876, 0.924) 0.973* (0.963, 0.980) 0.837 (0.758, 0.891) 0.865 (0.820, 0.899) 0.839 (0.623, 0.931)
4 0.942 (0.926, 0.955) 0.984 (0.978, 0.989) 0.901 (0.850, 0.935) 0.882 (0.843, 0.912) 0.898 (0.781, 0.954)
5 0.944 (0.928, 0.956) 0.988 (0.983, 0.991) 0.902 (0.852, 0.935) 0.883 (0.844, 0.913) 0.934 (0.855, 0.971)
6 0.966* (0.957, 0.974) 0.991 (0.988, 0.994) 0.941 (0.911, 0.962) 0.925 (0.899, 0.944) 0.940 (0.868, 0.973)
7 0.974 (0.966, 0.980) 0.994 (0.991, 0.995) 0.954 (0.930, 0.970) 0.953 (0.936, 0.965) 0.947 (0.883, 0.977)
8 0.989 (0.986, 0.992) 0.996 (0.994, 0.997) 0.982* (0.973, 0.988) 0.978* (0.970, 0.984) 0.990* (0.978, 0.996)
9 0.995 (0.993, 0.996) 0.998 (0.997, 0.999) 0.991 (0.986, 0.994) 0.994 (0.991, 0.995) 0.980 (0.954, 0.991)
Note.—Data in parentheses are 95% confidence intervals. High reliability is an interquartile range–to-median ratio of 30% or less; low reliability is an interquartile range–to-median ratio of greater 
than 30%.
* Represent intraclass correlation coefficient of 0.95 or greater between the number of repetitions and median value of 10 measurements. Steatosis data were available in 186 participants.
Figure 2
Figure 2: Bland-Altman plot of the differences in the shear-wave velocity (SWV) between median of six 
and median of 10 measurements. The solid line represents the mean of the difference in SWV; the dashed 
lines represent the 95% upper and lower limits of agreement. SD = standard deviation.
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5) was 11 (4.7%) with a median of 
10 measurements and 17 (7.3%) with 
six measurements. Of the additional 
six patients with discordance for the 
classification of significant fibrosis or 
cirrhosis, four patients had an IQR-to-
median ratio greater than 30% (Table 
4). When a median of 10 measurements 
were used, the percentage of patients 
who demonstrated discordance be-
tween the pSWE and histologic analysis 
increased from 14.7% (IQR-to-median 
ratio, 30%) to 31.7% (IQR-to-median 
ratio, .30%) and 2.0% (IQR-to-median 
ratio, 30%) to 9.8% (IQR-to-median 
ratio, .30%) in differentiating signifi-
cant fibrosis and severe fibrosis or cir-
rhosis, respectively.
Predictors of Lower Reliability
In the univariate analysis, advanced 
age (P = .038), significant fibrosis (P 
, .001) and moderate or marked ste-
atosis (P = .024) were associated with 
IQR-to-median ratio greater than 30%, 
whereas sex (P = .553), total bilirubin 
(P = .236), aspartate aminotransfer-
ase (P = .458), alanine aminotransfer-
ase (P = .064), g glutamyl transferase 
(P = .048), alkaline phosphatase (P = 
.099), international normalized ratio (P 
= .461), and platelet count (P = .393) 
were not significantly different between 
patients with IQR-to-median ratio of 
30% or less and of greater than 30%. 
In the multivariable logistic regression 
analysis, only significant fibrosis (B, 
0.795; standard error, 0.343; hazard 
ratio, 2.22; P , .020) was an indepen-
dent predictor of lower reliability (IQR-
to-median ratio, .30%) after adjusting 
for age and steatosis.
Discussion
In our study, a median of six SWV mea-
surements was the minimum number 
required that resulted in an error rate 
of less than 5% compared with a me-
dian of 10 measurements. In addition, 
the 95% agreement limit from the 
Bland Altman analysis was also compa-
rable to the 95% agreement limit from 
interobserver variability previously de-
scribed (26). The area under the re-
ceiver operating characteristic curve 
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rate with histologic evaluation for dif-
ferentiating between significant and se-
vere fibrosis or cirrhosis, respectively, 
compared with patients with higher re-
liability measurements (IQR-to-median 
ratio, 30%). However, the reduction 
of measurements from 10 to six re-
sulted in 1.1-fold and 1.7-fold increase 
in the discordance rate with histologic 
evaluation in differentiating significant 
and severe fibrosis, respectively. In our 
study, the percentage of discordance 
with histologic evaluation were more 
affected by IQR-to-median ratio than 
the number of measurements.
IQR-to-median ratio can only be 
calculated retrospectively because, to 
our knowledge, no reliability indicator 
is available at the time of acquiring the 
measurement. In view of the predefined 
threshold of a less than 5% measure-
ment error, the number of measure-
ments required compared with 10 
measurements will depend on the pro-
portion of measurements with an unre-
liable result (ie, IQR-to-median ratio of 
.30%). The presence of significant fi-
brosis was shown to be an independent 
predictor for an unreliable result con-
trary to previous evidence showing that 
cirrhosis does not influence the rate 
of reliable pSWE measurements (34). 
Unlike findings from a previous study 
by Bota et al (34), age and sex were 
not independent predictors for unre-
liable results. This may be because of 
the proportion of unreliable results in 
the previous publication also included 
measurement with success rate less 
than 60% and the proportion of pa-
tients with an unreliable result (6.4%) 
was significantly lower than the current 
study (35.3% of participants with 10 
measurements). This is comparable to 
the 42.4% figure published by Ferraioli 
et al (29) in a cohort of 255 patients 
by using pSWE with the ElastPQ tech-
nique (Philips, Eindhoven). However, 
despite over a third of participants who 
were considered to be unreliable, our 
results demonstrated that it is still pos-
sible to assess liver fibrosis with accept-
able accuracy (area under the receiver 
operating characteristic curve for sig-
nificant fibrosis, 0.822; area under the 
receiver operating characteristic curve 
same approach by comparing the ICC 
for the median of the initial two to nine 
measurements with the median of 10 
measurements. Other studies (28,29) 
that compared pSWE (ElastPQ, Philips, 
Endihoven; and Virtual Touch Quanti-
fication) with transient elastography 
(Fibroscan, Paris, France) showed 
that five measurements could be used 
instead of 10 without a significant ef-
fect on diagnostic performance. Similar 
findings have been observed with use 
of transient elastography where the di-
agnostic accuracy of detecting cirrhosis 
was not affected by using five valid mea-
surements instead of 10 with histologic 
evaluation as the comparison (30).
IQR-to-median ratio is a method 
for measuring data variability, and is 
recommended as a reliability indicator 
for transient elastography by the manu-
facturer (Echosens, Paris, France) (21). 
The importance of IQR-to-median ratio 
as a quality control measure for pSWE 
was observed in several studies (31,32). 
Increased accuracy for classifying fi-
brosis was noted when measurements 
that showed lower reliability (IQR-to-
median ratio, .30%) were excluded 
(29,31–33). Our results showed that 
use of higher reliability measurements 
(IQR-to-median ratio, 30%) can fur-
ther reduce the number of measure-
ment required from six to three by 
maintaining an ICC greater than 0.95 
with 10 measurements. Patients with 
lower reliability measurements (IQR-to-
median ratio, .30%) showed a 2.2-fold 
and 4.9-fold increase in discordance 
for differentiating significant fibrosis 
and severe fibrosis or cirrhosis by using 
the median of six measurements was 
slightly lower than the area under the 
receiver operating characteristic curve 
when the median of 10 measurements 
was used, but the difference was not 
statistically significant. The area under 
the receiver operating characteristic 
curve value by using the median of six 
measurements was within the range of 
published data (9,27). In our cohort of 
232 participants, the use of six mea-
surements instead of 10 only misclassi-
fied three patients with significant fibro-
sis and six patients with severe fibrosis 
or cirrhosis.
An increase in the number of mea-
surements (ie, from six to 10) resulted 
in greater reduction in the percentage 
of discordant patients with severe fi-
brosis or cirrhosis (7.3% from six mea-
surements vs 4.7% from 10 measure-
ments) than for those with significant 
fibrosis (22.0% from six measurements 
vs 20.7% from 10 measurements).
Previous studies have used the me-
dian or the mean of 10 measurements 
as routine practice. Our data suggest 
that acquiring fewer measurements 
will have a limited effect on the di-
agnostic performance of pSWE with 
only limited disagreement (nine of 232 
[3.9%] cases) versus histologic evalua-
tion, potentially saving clinic time. Yoon 
et al (18) also suggested that the op-
timal minimum number of SWE mea-
surements required was six in their 
cohort of 86 patients; they used the 
Table 4
Discordance between Point Shear-Wave Elastography and Histologic Analysis in the 
Overall Cohort and Subgroups
Parameter
Significant Fibrosis Severe Fibrosis or Cirrhosis 
Median of 6 pSWE Median of 10 pSWE Median of 6 pSWE Median of 10 pSWE
IQR-to-median ratio,  
30% (n = 150)
24 (16.0) 22 (14.7) 5 (3.3) 3 (2.0)
IQR-to-median ratio,  
.30% (n = 82)
27 (32.9) 26 (31.7) 12 (14.6) 8 (9.8)
Overall (n = 232) 51 (22.0) 48 (20.7) 17 (7.3) 11 (4.7)
Note.—Data are number of patients; data in parentheses are percentages. Significant fibrosis refers to Ishak stage 3 or greater; 
severe fibrosis or cirrhosis refers to Ishak stage 5 or greater. IQR = interquartile range, pSWE = point shear-wave elastography.
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measurements by acoustic radiation force 
impulse imaging of the liver: a study in 
healthy volunteers. J Ultrasound Med 2011; 
30(7):975–979.
 7. Colombo S, Buonocore M, Del Poggio A, et 
al. Head-to-head comparison of transient elas-
tography (TE), real-time tissue elastography 
(RTE), and acoustic radiation force impulse 
(ARFI) imaging in the diagnosis of liver fibro-
sis. J Gastroenterol 2012;47(4):461–469.
 8. Ferraioli G, Tinelli C, Lissandrin R, et al. 
Point shear wave elastography method for 
assessing liver stiffness. World J Gastroen-
terol 2014;20(16):4787–4796.
 9. Friedrich-Rust M, Wunder K, Kriener S, 
et al. Liver fibrosis in viral hepatitis: non-
invasive assessment with acoustic radiation 
force impulse imaging versus transient elas-
tography. Radiology 2009;252(2):595–604.
 10. Bota S, Sporea I, Sirli R, Popescu A, Danila 
M, Costachescu D. Intra- and interop-
erator reproducibility of acoustic radiation 
force impulse (ARFI) elastography--prelim-
inary results. Ultrasound Med Biol 2012;38 
(7):1103–1108.
 11. D’Onofrio M, Gallotti A, Mucelli RP. Tissue 
quantification with acoustic radiation force 
impulse imaging: Measurement repeatability 
and normal values in the healthy liver. AJR 
Am J Roentgenol 2010;195(1):132–136.
 12. Fang C, Konstantatou E, Romanos O, Yusuf 
GT, Quinlan DJ, Sidhu PS. Reproducibility 
of 2-Dimensional Shear Wave Elastography 
Assessment of the Liver: A Direct Compari-
son With Point Shear Wave Elastography in 
Healthy Volunteers. J Ultrasound Med 2017;36 
(8):1563–1569.
 13. Jaffer OS, Lung PFC, Bosanac D, et al. Acous-
tic radiation force impulse quantification: re-
peatability of measurements in selected liver 
segments and influence of age, body mass 
index and liver capsule-to-box distance. Br J 
Radiol 2012;85(1018):e858–e863.
 14. European Association for the Study of the 
Liver. EASL recommendations on treatment 
of hepatitis C 2014. J Hepatol 2014;61(2): 
373–395.
 15. European Association for the Study of the 
Liver. Electronic address: easloffice@easlof-
fice.eu; European Association for the Study of 
the Liver. EASL 2017 Clinical Practice Guide-
lines on the management of hepatitis B virus 
infection. J Hepatol 2017;67(2):370–398.
 16. Takahashi H, Ono N, Eguchi Y, et al. 
Evaluation of acoustic radiation force im-
pulse elastography for fibrosis staging of 
chronic liver disease: a pilot study. Liver Int 
2010;30(4):538–545.
 17. Piscaglia F, Salvatore V, Di Donato R, et al. 
Accuracy of VirtualTouch Acoustic Radiation 
In summary, the reliability of pSWE 
measurements has a greater effect on 
diagnostic accuracy than the number 
of measurements. Although significant 
fibrosis is associated with lower reli-
ability, fewer than 10 measurements 
can accurately assess liver stiffness by 
using pSWE.
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